Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT
Evaluation of 2%Bromelain Gel With 0.2%Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing in Stage II/III and Grade B Periodontitis -Randomized Control Clinical Trail
Krishnadevaraya College of Dental Sciences & Hospital
36 participants
Jul 1, 2024
INTERVENTIONAL
Conditions
Summary
The current study is a prospective randomised study Evaluation of 2%Bromelain Gel With 0.2%Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing in Stage II/III and Grade B Periodontitis
Eligibility
Inclusion Criteria6
- Patient with have chronic periodontitis in the age group between 30-50 years.
- Patients having ≥20 teeth.
- Patients with radiographic evidence of bone loss in atleast two teeth.
- Patients who are systematically healthy.
- Patients with localized pockets with probing depth of ≤ 5mm.
- Patients who are cooperative and able to attend the hospital for regular follow-up.
Exclusion Criteria4
- Patients who have received any surgical or nonsurgical therapy during past 6months
- Pregnant or lactating females.
- Use of systemic antibiotics in the past 6 months.
- Patient who are not willing to give a written informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
bromelain gel is prepared from bromelain capsules in laboratory
chlorhexidine gel is prepared from mouth wash
Scaling and root planing was done with ultra sonic and hand scaling
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06505759